Obesity is a known risk factor for acid reflux, and the weight loss achieved through semaglutide treatment has, in some cases, led to a reduction in acid reflux symptoms
At IDWeek 2023, senior investigator Professor Grace McComsey of Case Western Reserve University in Ohio reported that semaglutide significantly decreased central fat in people with lipohypertrophy, primarily driven by a reduction in visceral adipose tissue
Second, GLP-1RAs reduce neuroinflammatory changes in preclinical models
doi: 10.3389/fneur.2021.637890 47
The drug's mechanism targets interleukin-17A (IL-17A), a pro-inflammatory cytokine that drives the pathological immune response in autoimmune conditions
Try to avoid consuming caffeine after roughly 2 p.m., or eight hours prior to bedtime, whichever is longer